TR200101893T2 - Antiviral maddeler olarak 4-okso-1,4 dihidro -3- kuinolinkarboksamitler. - Google Patents

Antiviral maddeler olarak 4-okso-1,4 dihidro -3- kuinolinkarboksamitler.

Info

Publication number
TR200101893T2
TR200101893T2 TR2001/01893T TR200101893T TR200101893T2 TR 200101893 T2 TR200101893 T2 TR 200101893T2 TR 2001/01893 T TR2001/01893 T TR 2001/01893T TR 200101893 T TR200101893 T TR 200101893T TR 200101893 T2 TR200101893 T2 TR 200101893T2
Authority
TR
Turkey
Prior art keywords
quinolinecarboxamides
dihydro
oxo
formula
antiviral agents
Prior art date
Application number
TR2001/01893T
Other languages
English (en)
Inventor
Ronald Turner Steven
Walter Strohbach Joseph
Thaisrivongs Suvit
A. Vaillancourt Valerie
E. Schnute Mark
Scott Allen
Original Assignee
Pharmacia & Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Company filed Critical Pharmacia & Upjohn Company
Publication of TR200101893T2 publication Critical patent/TR200101893T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Formül I bir bilesik, (FORMÜL) burada, R1 istege bagli olarak hidroksi veya NR4R5 ile ikameli C1-7 alkildir; R2 hidroksi veya NR4R5 ile ikameli C1-7 alkildir; R3H, F veya C1-7 alkoksidir; R4 ve R5 N ile birlikte azot, oksijen ve kükürtten olusan gruptan seçilmis 1-3 heteroatoma sahip 5 veya 6 unsurlu heteroksiklik bir yarimdir, burada kükürt bir (1) veya iki (2) oksijen atomu ile ikame edilebilir; ve bunun farmasötik açidan kabul edilebilir bir tuzdur. Mevcut bulusa mahsus formül I bilesikler intiviral maddeler olarak faydalidirlar.
TR2001/01893T 1999-01-08 1999-12-22 Antiviral maddeler olarak 4-okso-1,4 dihidro -3- kuinolinkarboksamitler. TR200101893T2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11511399P 1999-01-08 1999-01-08
US13839099P 1999-06-09 1999-06-09
US14061499P 1999-06-23 1999-06-23

Publications (1)

Publication Number Publication Date
TR200101893T2 true TR200101893T2 (tr) 2001-11-21

Family

ID=27381602

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01893T TR200101893T2 (tr) 1999-01-08 1999-12-22 Antiviral maddeler olarak 4-okso-1,4 dihidro -3- kuinolinkarboksamitler.

Country Status (27)

Country Link
US (1) US6248736B1 (tr)
EP (1) EP1140851B1 (tr)
JP (1) JP2002534417A (tr)
KR (1) KR20010101428A (tr)
CN (1) CN1132818C (tr)
AT (1) ATE275134T1 (tr)
AU (1) AU2158300A (tr)
BR (1) BR9916781A (tr)
CA (1) CA2353634A1 (tr)
CO (1) CO5150150A1 (tr)
CZ (1) CZ20012458A3 (tr)
DE (1) DE69919897T2 (tr)
EA (1) EA004043B1 (tr)
ES (1) ES2228162T3 (tr)
HU (1) HUP0105142A3 (tr)
ID (1) ID29452A (tr)
IL (1) IL144170A0 (tr)
MY (1) MY118904A (tr)
NO (1) NO320396B1 (tr)
NZ (1) NZ512823A (tr)
PE (1) PE20001337A1 (tr)
PL (1) PL348769A1 (tr)
PT (1) PT1140851E (tr)
SK (1) SK8312001A3 (tr)
TR (1) TR200101893T2 (tr)
TW (1) TW593281B (tr)
WO (1) WO2000040563A1 (tr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730682B2 (en) 2000-07-12 2004-05-04 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
US6559145B2 (en) 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
US6562822B2 (en) 2000-07-12 2003-05-13 Pharmacia & Upjohn Company Heterocyle carboxamides as antiviral agents
US6682892B2 (en) 2000-07-13 2004-01-27 Pharmacia & Upjohn Company Method for treating herpes viruses
WO2002070487A1 (en) 2001-03-01 2002-09-12 Pharmacia & Upjohn Company Substituted quinolinecarboxamides as antiviral agents
WO2003020728A1 (en) 2001-08-30 2003-03-13 Pharmacia & Upjohn Company 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS
AR038294A1 (es) 2002-01-14 2005-01-12 Upjohn Co Oxotieno(3,2-b)piridincarboxamidas como agentes antivirales
AR038117A1 (es) 2002-01-14 2004-12-29 Upjohn Co Agentes antivirales derivados de la 4- oxo-4,7 -dihidrofuro [2,3-b]piridin-5-carboxamida
AR038118A1 (es) 2002-01-14 2004-12-29 Upjohn Co Compuestos derivados de la bencinamida del acido 7-oxo-4,7-dihidrotien[2,3-b[piridin-6-carboxilico 3-sustituido que son utiles como antivirales
AU2003262947A1 (en) * 2002-08-30 2004-03-19 Pharmacia And Upjohn Company Method of preventing or treating atherosclerosis or restenosis
US20040176366A1 (en) * 2002-08-30 2004-09-09 Wathen Michael W Method of preventing or treating atherosclerosis or restenosis
US7176220B2 (en) * 2002-11-20 2007-02-13 Japan Tobacco Inc. 4-oxoquinoline compound and use thereof as pharmaceutical agent
CN100375742C (zh) * 2002-11-20 2008-03-19 日本烟草产业株式会社 4-氧代喹啉化合物及其用途
WO2005009971A1 (ja) 2003-07-24 2005-02-03 Astellas Pharma Inc. キノロン誘導体又はその塩
MY134672A (en) * 2004-05-20 2007-12-31 Japan Tobacco Inc Stable crystal of 4-oxoquinoline compound
US7531554B2 (en) 2004-05-20 2009-05-12 Japan Tobacco Inc. 4-oxoquinoline compound and use thereof as HIV integrase inhibitor
US8633219B2 (en) * 2004-05-21 2014-01-21 Japan Tobacco Inc. Combination therapy
CA2881078C (en) 2004-06-24 2018-10-02 Vertex Pharmaceuticals Incorporated Modulators of atp-binding cassette transporters
US20070032522A1 (en) * 2005-07-01 2007-02-08 Kumar Dange V Antiviral agents
LT1993360T (lt) 2005-12-28 2017-06-12 Vertex Pharmaceuticals Incorporated N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido kieta forma
EP1978960A4 (en) * 2006-02-01 2009-12-02 Japan Tobacco Inc USE OF 6- (3-CHLORO-2-FLUORBENZYL) -1 - [(2S) -1-HYDROXY-3-METHYLBUTAN-2-YL [-7-METHOXY-4-OXO-1,4-DIHYDROCHINOLINE-3- CARBOXYLIC ACID OR SALT THEREOF FOR THE TREATMENT OF RETROVIRUS INFECTION
JP4669040B2 (ja) * 2006-03-06 2011-04-13 日本たばこ産業株式会社 ４−オキソキノリン化合物の製造方法
DE102008036099B4 (de) 2008-08-04 2014-02-13 Steag Power Saar Gmbh Entstickungsanlage
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
SI3330255T1 (sl) 2009-03-20 2021-03-31 Vertex Pharmaceuticals Incorporated Postopek izdelave regulatorja transmembranske prevodnosti pri cistični fibrozi
WO2011004389A2 (en) 2009-06-18 2011-01-13 Matrix Laboratories Ltd An improved process for the preparation of elvitegravir
KR20130100300A (ko) * 2010-08-27 2013-09-10 그뤼넨탈 게엠베하 Ｋｃｎｑ２／３ 조절제로서의 치환된 ２-옥시-퀴놀린-３-카복스아미드
EP2819670B1 (en) 2012-02-27 2026-05-20 Vertex Pharmaceuticals Incorporated Pharmaceutical Composition and Their Administration
WO2014062655A1 (en) 2012-10-16 2014-04-24 Janssen Pharmaceutica Nv HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt
MY189505A (en) 2012-10-16 2022-02-16 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of roryt
HK1213887A1 (zh) 2012-10-16 2016-07-15 Janssen Pharmaceutica N.V. RORγt的苯基连接的喹啉基调节剂
US9284308B2 (en) 2013-10-15 2016-03-15 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of RORγt
US9221804B2 (en) 2013-10-15 2015-12-29 Janssen Pharmaceutica Nv Secondary alcohol quinolinyl modulators of RORγt
CA2927182A1 (en) 2013-10-15 2015-04-23 Janssen Pharmaceutica Nv Quinolinyl modulators of ror.gamma.t
US9403816B2 (en) 2013-10-15 2016-08-02 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of RORγt
US10555941B2 (en) 2013-10-15 2020-02-11 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of RORγt
CA2926339A1 (en) 2013-10-15 2015-04-23 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of roryt
US9328095B2 (en) 2013-10-15 2016-05-03 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORgammat
CA2963945C (en) 2014-10-07 2023-01-10 Vertex Pharmaceuticals Incorporated Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
US11072610B2 (en) 2018-09-12 2021-07-27 Novartis Ag Antiviral pyridopyrazinedione compounds
CN114667285B (zh) 2019-09-26 2025-08-08 诺华股份有限公司 抗病毒吡唑并吡啶酮化合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593810B1 (fr) * 1986-01-24 1988-04-22 Sanofi Sa Derives de la quinoleine, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant
US4786644A (en) * 1987-11-27 1988-11-22 Hoechst-Roussel Pharmaceuticals Inc. 1-aryl-3-quinolinecarboxamide
US4959363A (en) * 1989-06-23 1990-09-25 Sterling Drug Inc. Quinolonecarboxamide compounds, their preparation and use as antivirals.
US5378694A (en) * 1990-09-07 1995-01-03 Schering Corporation Acyl and alkoxy substituted quinolines
US5175151A (en) 1990-09-07 1992-12-29 Schering Corporation Antiviral compounds and antihypertensive compounds
EP0531578B1 (en) 1991-09-10 1995-12-20 Agfa-Gevaert N.V. Thermally transferable fluorescent compounds
PT841929E (pt) 1995-08-02 2003-09-30 Darwin Discovery Ltd Quinolonas e sua utilizacao terapeutica
CA2229201A1 (en) 1995-10-19 1997-04-24 Satoshi Sasaki Quinoline derivatives, their production and use
PT944619E (pt) 1996-11-27 2007-01-31 Bristol Myers Squibb Pharma Co Novos antagonistas dos receptores da integrina
EP1042295B1 (en) 1997-12-22 2005-09-07 Pharmacia & Upjohn Company LLC 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents

Also Published As

Publication number Publication date
US6248736B1 (en) 2001-06-19
CN1332729A (zh) 2002-01-23
ID29452A (id) 2001-08-30
SK8312001A3 (en) 2001-12-03
MY118904A (en) 2005-02-28
KR20010101428A (ko) 2001-11-14
DE69919897D1 (en) 2004-10-07
NO20013379D0 (no) 2001-07-06
PE20001337A1 (es) 2000-11-23
CO5150150A1 (es) 2002-04-29
ES2228162T3 (es) 2005-04-01
HUP0105142A3 (en) 2002-05-28
NZ512823A (en) 2003-10-31
CZ20012458A3 (cs) 2001-12-12
HK1041879A1 (en) 2002-07-26
NO320396B1 (no) 2005-11-28
HUP0105142A2 (hu) 2002-04-29
EP1140851A1 (en) 2001-10-10
EA200100755A1 (ru) 2001-12-24
CN1132818C (zh) 2003-12-31
PL348769A1 (en) 2002-06-17
EP1140851B1 (en) 2004-09-01
WO2000040563A1 (en) 2000-07-13
DE69919897T2 (de) 2005-09-08
AU2158300A (en) 2000-07-24
TW593281B (en) 2004-06-21
BR9916781A (pt) 2001-12-04
CA2353634A1 (en) 2000-07-13
PT1140851E (pt) 2004-12-31
IL144170A0 (en) 2002-05-23
ATE275134T1 (de) 2004-09-15
JP2002534417A (ja) 2002-10-15
EA004043B1 (ru) 2003-12-25
NO20013379L (no) 2001-07-06

Similar Documents

Publication Publication Date Title
NO20013379D0 (no) 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler
ATE270278T1 (de) Phthalazinone pde iii/iv hemmer
DK1054874T3 (da) Substituerede aminophenylisoxazolinderivater, der er anvendelige som antimokrobielle midler
DE69213216D1 (de) Quarternäre panthenolderivate und ihre verwendung
ES8600288A1 (es) Un procedimiento para la preparacion de derivados de quinolina.
MXPA02004440A (es) Derivados de pirrol como inhibidores de la fosfodiesterasa vii.
PT918776E (pt) Sintese total de acilfulvenos antitumorais
DE69505470D1 (de) Pyrrolocarbazol
DK1042319T3 (da) Dihydrobenzofuraner
TR200100603T2 (tr) Pirazin bileşikleri
PT1044186E (pt) Composto 2-benzilamino-2-fenil-acetamida substituidos
TR200200360T2 (tr) Antibakteriyel aktif maddeler.
SE8503415D0 (sv) Novel isoindolinyl-alkyl-piperazines
ATE259813T1 (de) Triazolopyrimidinderivate
TR200003652T2 (tr) Glisin antagonistleri olarak tetrahidrokuinolin türevleri.
DE60036558D1 (de) Phthalazinon-derivate als pde 4 hemmer
NZ336091A (en) Aqueous disinfecting cleaning composition
DK0623131T3 (da) Alkylderivater af trazodon med CNS-aktivitet
KR960702463A (ko) Dc-89 유도체[dc-89 derivative]
DK0594329T3 (da) Antimikrobielle midler, der omfatter polykvaternære ammoniumforbindelser
NZ333854A (en) Intermediates for the preparation of 2-imidazoline-5-ones
EA200000681A1 (ru) Фунгицидная смесь на базе амидных соединений и производных пиридина
KR920012100A (ko) 비스포스폰산 유도체, 이의 제조 및 용도
TW330147B (en) Halogenobenzimidazoles, their preparation processes and their use
BR8003950A (pt) Composicoes herbicidas, baseadas em derivados de m-anilido-uretana